Endoplasmic reticulum stress is implicated in retinal inflammation and diabetic retinopathy

FEBS Letters

Volumn 583, Issue 9, 2009, Pages 1521-1527

  Li, Jingming ^a   Wang, Joshua J ^a   Yu, Qiang ^b   Wang, Min ^a   Zhang, Sarah X ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Diabetic retinopathy; ER stress; Human retinal endothelial cell; Inflammation; Oxygen induced retinopathy

Indexed keywords

CHAPERONE; CHAPERONE 4 PHENYL BUTYRIC ACID; TUNICAMYCIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; HUMAN; HUMAN CELL; HYPOXIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINITIS;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DIABETIC RETINOPATHY; DNA PRIMERS; ENDOPLASMIC RETICULUM; ENDORIBONUCLEASES; EUKARYOTIC INITIATION FACTOR-2; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MOLECULAR CHAPERONES; OXIDATIVE STRESS; PHENYLBUTYRATES; PROTEIN-SERINE-THREONINE KINASES; RETINA; RETINITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; TUNICAMYCIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MUS;

EID: 67349269219     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.04.007     Document Type: Article

References (40)

1. Frank R.N. Diabetic retinopathy. New Engl. J. Med. 350 (2004) 48-58
2. Kern T.S. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp. Diabetes Res. 2007 (2007) 95103
3. Joussen A.M., et al. Suppression of diabetic retinopathy with angiopoietin-1. Am. J. Pathol. 160 (2002) 1683-1693 (comment)
4. Zhang S.X., Wang J.J., Gao G., Shao C., Mott R., and Ma J.-X. Pigment epithelium-derived factor (PEDF) is an endogenous anti-inflammatory factor. FASEB J. 20 (2006) 323-325
5. Mitamura Y., Takeuchi S., Matsuda A., Tagawa Y., Mizue Y., and Nishihira J. Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy. Ophthalmologica 215 (2001) 415-418
6. Ogata N., Nishikawa M., Nishimura T., Mitsuma Y., and Matsumura M. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am. J. Ophthalmol. 134 (2002) 348-353
7. Joussen A.M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Dohmen S., and Adamis A.P. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J. 16 (2002) 438-440
8. Ishida S., et al. VEGF164 is proinflammatory in the diabetic retina. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2155-2162
9. Ozcan U., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306 (2004) 457-461
10. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., Görgün C.Z., and Hotamisligil G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313 (2006) 1137-1140
11. Song B., Scheuner D., Ron D., Pennathur S., and Kaufman R.J. Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J. Clin. Invest. 118 (2008) 3378-3389
12. Gargalovic P.S., et al. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2490-2496
13. Hu P., Han Z., Couvillon A.D., Kaufman R.J., and Exton J.H. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression. Mol. Cell Biol. 26 (2006) 3071-3084
14. Zhang K., and Kaufman R.J. From endoplasmic-reticulum stress to the inflammatory response. Nature 454 (2008) 455-462
15. Gargalovic P.S., et al. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc. Natl. Acad. Sci. USA 103 (2006) 12741-12746
16. Roybal C.N., Yang S., Sun C.W., Hurtado D., Vander Jagt D.L., Townes T.M., and Abcouwer S.F. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J. Biol. Chem. 279 (2004) 14844-14852
17. Roybal C.N., Hunsaker L.A., Barbash O., Vander Jagt D.L., and Abcouwer S.F. The oxidative stressor arsenite activates vascular endothelial growth factor mRNA transcription by an ATF4-dependent mechanism. J. Biol. Chem. 280 (2005) 20331-20339
18. Malabanan K.P., Kanellakis P., Bobik A., and Khachigian L.M. Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury. Circ. Res. 103 (2008) 378-387
19. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., and D'Amore P.A. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35 (1994) 101-111
20. Zhang S.X., Sima J., Wang J.J., Shao C., Fant J., and Ma J.X. Systemic and periocular deliveries of plasminogen kringle 5 reduce vascular leakage in rat models of oxygen-induced retinopathy and diabetes. Curr. Eye Res. 30 (2005) 681-689
21. Zhang S.X., Sima J., Shao C., Fant J., Chen Y., Rohrer B., Gao G., and Ma J.-X. Plasminogen kringle 5 reduces vascular leakage in the retina of rat model of the oxygen-induced retinopathy and diabetes. Diabetologia 47 (2004) 124-131
22. Tirosh B., Iwakoshi N.N., Glimcher L.H., and Ploegh H.L. Rapid turnover of unspliced Xbp-1 as a factor that modulates the unfolded protein response. J. Biol. Chem. 281 (2006) 5852-5860
23. Zhang S.X., Wang J.J., Gao G., Parke K., and Ma J.X. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J. Mol. Endocrinol. 37 (2006) 1-12
24. Barber A.J., et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest. Ophthalmol. Vis. Sci. 46 (2005) 2210-2218
25. Ron D., and Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8 (2007) 519-529
26. Chen J., and Smith L.E. Retinopathy of prematurity. Angiogenesis 10 (2007) 133-140
27. Zhang S.X., Ma J.-X., Sima J., Chen Y., Hu M.S., Ottlecz A., and Lambrou G.N. Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy. Am. J. Pathol. 166 (2005) 313-321
28. de Gooyer T.E., Stevenson K.A., Humphries P., Simpson D.A., Gardiner T.A., and Stitt A.W. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest. Ophthalmol. Vis. Sci. 47 (2006) 5561-5568
29. Sanson, M., et al. (2008) Oxidized low-density lipoprotein triggers endoplasmic reticulum stress in vascular Cells. Prevention by oxygen-regulated protein 150 expression. Circ Res. (Epub ahead of print).
30. Linsenmeier R.A., Braun R.D., McRipley M.A., Padnick L.B., Ahmed J., Hatchell D.L., McLeod D.S., and Lutty G.A. Retinal hypoxia in long-term diabetic cats. Invest. Ophthalmol. Vis. Sci. 39 (1998) 1647-1657
31. Nguyen Q.D., Shah S.M., Van Anden E., Sung J.U., Vitale S., and Campochiaro P.A. Supplemental oxygen improves diabetic macular edema: a pilot study. Invest. Ophthalmol. Vis. Sci. 45 (2004) 617-624
32. Zhang S.X., and Ma J.X. Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy. Prog. Retin. Eye Res. 26 (2007) 1-37
33. Braun L., Kardon T., Reisz-Porszasz Z.S., Banhegyi G., and Mandl J. The regulation of the induction of vascular endothelial growth factor at the onset of diabetes in spontaneously diabetic rats. Life Sci. 69 (2001) 2533-2542
34. Funatsu H., Noma H., Mimura T., Eguchi S., and Hori S. Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 116 (2009) 73-79
35. Kowluru R.A., and Chan P.S. Oxidative stress and diabetic retinopathy. Exp. Diabetes Res. (2007) 43603
36. Dickhout J.G., Hossain G.S., Pozza L.M., Zhou J., Lhoták S., and Austin R.C. Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2623-2629
37. Lange P.S., Chavez J.C., Pinto J.T., Coppola G., Sun C.W., Townes T.M., Geschwind D.H., and Ratan R.R. ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo. J. Exp. Med. 205 (2008) 1227-1242
38. Malhotra J.D., Miao H., Zhang K., Wolfson A., Pennathur S., Pipe S.W., and Kaufman R.J. Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proc. Natl. Acad. Sci. USA 105 (2008) 18525-18530
39. Saito Y., Geisen P., Uppal A., and Hartnett M.E. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity. Mol. Vis. 13 (2007) 840-853
40. Saito Y., Uppal A., Byfield G., Budd S., Geisen P., and Hartnett M.E. Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model. Invest. Ophthalmol. Vis. Sci. 49 (2008) 1591-1598